MannKind Corporation Reports 2017 Fourth Quarter and Full Year Financial Results Pharmaceutical Investing
Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Tetraphase Pharmaceuticals Announces FDA Acceptance for Filing of its NDA Submission for Eravacycline Pharmaceutical Investing
Actinium Pharmaceuticals Announces Activation of Sixteenth Clinical Trial Site in the Pivotal Phase 3 SIERRA Trial for Iomab-B Pharmaceutical Investing
Amarin Reports Record Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Operations Pharmaceutical Investing
Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017 Pharmaceutical Investing
